(Q41323051)

29 September 2017

Immediate and sustained haemodynamic effects of prazosin during upright exercise in man. (English)

1 reference

29 September 2017

1 reference

Silke B

1

1 reference

29 September 2017

Hendry WG

series ordinal

2

1 reference

29 September 2017

Taylor SH

series ordinal

3

1 reference

29 September 2017

1 December 1981

1 reference

29 September 2017

British Heart Journal

1 reference

29 September 2017

46

1 reference

29 September 2017

6

1 reference

29 September 2017

663-670

1 reference

Prazosin protein binding in health and disease.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482714

Clinical pharmacokinetics of prazosin

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482714

Management of refractory congestive heart failure with prazosin

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482714

Clinical, hemodynamic, and neuroendocrine effects of chronic prazosin therapy for congestive heart failure

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482714

Clinical, electrocardiographic, and haemodynamic effects of digitalis (ouabain) in angina pectoris

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482714

Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482714

Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, h

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482714

Effects of prazosin on forearm resistance and capacitance vessels

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482714

Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482714

Comparison of effects of tolmesoxide (RX71107), diazoxide, hydrallazine, prazosin, glyceryl trinitrate and sodium nitroprusside on forearm arteries and dorsal hand veins of man

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482714

Effect of prazosin vs placebo on chronic left ventricular heart failure

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482714

Symposium on vasodilator and inotropic therapy of heart failure. Symposium perspective

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482714

Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482714

Attenuation of Prazosin Effect on Cardiac Output in Chronic Heart Failure

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482714

Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482714

Influence of congestive heart failure on prazosin kinetics

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482714

Phentolamine for vasodilator treatment of severe heart-failure

11 June 2018

1 reference

12 December 2020

Vasodilator therapy--a physiologic approach to the treatment of heart failure

1 reference

12 December 2020

Clinical pharmacology and therapeutic application of prazosin in acute and chronic refractory congestive heart failure. Balanced systemic venous and arterial dilation improving pulmonary congestion and cardiac output

1 reference

12 December 2020

Long-term therapy of heart failure with prazosin: a randomized double blind trial

1 reference

12 December 2020

Altered prazosin pharmacokinetics in congestive heart failure

1 reference

12 December 2020

Effect of prazosin on renal function in congestive heart failure

1 reference

12 December 2020

Pharmacodynamic basis of the use of vasodilators in the treatment of heart failure

1 reference

12 December 2020

Pharmacokinetic and Pharmacodynamic Studies with Prazosin in Chronic Heart Failure

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.46.6.663

1 reference

29 September 2017

1 reference

29 September 2017

PubMed publication ID

7317235

1 reference